Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

RemeGen completes phase II study of telitacicept in IgAN

Aug. 12, 2021

Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS

Aug. 11, 2021

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

Aug. 10, 2021

Phase I data with ANG-3070 pave way for phase II study in primary proteinuric kidney diseases

Aug. 3, 2021

CIHR grant supports Arch's evaluation of LSALT in chronic kidney and lung diseases

July 15, 2021

Chinese investigators divulge P2X3 receptor antagonists

July 6, 2021

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

June 29, 2021

FDA clears IND for clinical evaluation of CLBS-201 for diabetic kidney disease

June 23, 2021

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

June 14, 2021

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

June 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...